GTCbio

Dr. Xi Chen, Assistant Professor in the Department of Chemistry at the University of California, Davis will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Chen will speak on combinatorial chemoenzymatic synthesis and high-throughput screening of carbohydrates. Although the vital roles of carbohydrates in biomolecular...

Dr. Taosheng Chen, Director of HTS, St. Jude Children’s Research Hospital will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Chen will speak on a chemical biology approach to identify modulators of xenobiotic receptor PXR. Pregnane X receptor (PXR) has been established as a key xenobiotic receptor regulating...

Dr. Clay Scott, Associate Director of the Lead Generation Department at AstraZeneca will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Clay will speak on experiences in lead generation focusing on cellular dielectric spectroscopy as a platform technology for GPCR screening. Cellular dielectric spectroscopy (CDS) is...

Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful applications of high content assays using confocal microscopy. Traditional screening has long been associated...

Dr. Didier Leroy, Team Leader of Lead Discovery Technologies, Geneva Research Center at Merck-Serono will be presenting at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 4-5, 2008 in San Diego, CA. As the Team Leader at Merck-Serono, Dr. Leroy’s goal in oncology is to develop novel therapies that specifically target cancer cells and are more tolerable for patients. His...

Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. Dr. Taylor will provide an overview on the protein kinase superfamily, which is one of the largest and most important for biology. These enzymes serve as master switches for regulating a myriad of biological...

Award Winning Online Jewelry Store Plans to Launch a Marketing Campaign to Target Potential Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. Dr. Dabbagh’s presentation will cover P38 MAP Kinases and the important roles they play in inflammatory responses. Since P38...

Jane S. Lebkowski, Senior Vice President of Regenerative Medicine at Geron will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. Dr. Lebkowski will discuss the use human embryonic stem cells to advance technology for therapeutic applications. Human Embryonic Stem Cells (hESCs) can be propagated indefinitely yet differentiate to...

Edward Lanphier, President & Chief Executive Officer at Sangamo BioSciences, which published a new study last October indicating that its technology could be used to modify the genomes in stem cells, create stem cell lines that mimic disease, and modify stem cells to treat diseases, will present at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. Dr...

Bruce Wentworth, Senior Director of Cardiovascular Research at Genzyme will give a presentation entitled “Retention of Cells after Transplantation” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. Dr. Wentworth’s group has investigated the retention of syngeneic cultured cells (skeletal myoblasts, SM, and bone marrow stromal cells, BMSC) after...